Clinical Trials
2 trialsNCT05318443 2023-12-27
A Study Exploring Efficacy of SIBP04 in Subjects With Non-squamous Non-small Cell Lung Cancer
Shanghai Institute Of Biological Products
Phase 3 Completed
NCT04012619 2023-08-03
Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer
Sichuan University
Phase 1 Completed